Details for New Drug Application (NDA): 203030
✉ Email this page to a colleague
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 203030
Tradename: | LOSARTAN POTASSIUM |
Applicant: | Unichem |
Ingredient: | losartan potassium |
Patents: | 0 |
Pharmacology for NDA: 203030
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 203030
Suppliers and Packaging for NDA: 203030
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 203030 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-144 | 29300-144-01 | 100 TABLET in 1 BOTTLE, PLASTIC (29300-144-01) |
LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 203030 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-144 | 29300-144-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-144-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 14, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Oct 14, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Oct 14, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription